COPD is a risk factor for COVID-19, but does not confer increased severity of the disease
Jae Seok Jeong, Jong Seung Kim, Yeon Seok You, Sang Woo Yeom, Yong Chul Lee
Abstract
Epidemiologic studies suggest that COPD is associated with an increased risk of poor outcome in patients with COVID-19, although they failed to demonstrate COPD as a risk factor for acquiring COVID-19. However, most data have come from a limited global population. In this nationwide cohort study based on the Korean national health insurance claims-based database, COPD is associated with increased risk for COVID-19 and having COPD does not seem to confer substantial risk for severe COVID-19 and mortality. These findings indicate that heterogeneity in the populations across many countries may complicate the net effects of COPD on the COVID-19-related outcomes.
Topics & Concepts
COPDMedicineCoronavirus disease 2019 (COVID-19)Risk factorCohortCohort studyPopulationDiseaseIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineEnvironmental healthInfectious disease (medical specialty)COVID-19 Clinical Research StudiesChronic Obstructive Pulmonary Disease (COPD) ResearchLong-Term Effects of COVID-19